Fig. 2From: Anti-high mobility group box protein 1 monoclonal antibody downregulating P-glycoprotein as novel epilepsy therapeuticsAnti-HMGB1 mAb can inhibit status epilepticus and epileptogenesis. HMGB1; High Mobility Group Box 1, BBB; blood brain barrierBack to article page